An orally bioavailable agent that is selective towards adrenal cortex cells with potential antitumor activity. Upon administration, ATR-101 selectively kills adrenal and adrenal cancer cells, through an unknown mechanism. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
